Inventor
Sharat Singh
Inventor
San Jose, CA, US
Overview
Patents· 115 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
G01Nprimary
G01NInvestigating or analysing materials by determining their chemical or physical properties36%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests11%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms7%
C07DHeterocyclic compounds7%
C40BCombinatorial chemistry7%
Y10TTechnical subjects covered by former us classification6%
C07HSugars6%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations4%
C07KPeptides3%
B01LChemical or physical laboratory apparatus for general use2%
PatentTitleYear
10,866,244Ultra bright dimeric or polymeric dyes with spacing linker groups202010,865,310Ultra bright dimeric or polymeric dyes202010,794,906Assays for detecting neutralizing autoantibodies to biologic therapy202010,697,961Methods for predicting post-operative recurrence of Crohn's disease202010,697,967Methods for predicting response of triple-negative breast cancer to therapy202010,640,830Drug selection for non-small cell lung cancer therapy202010,588,608Sampling systems and related materials and methods202010,571,467Methods for prediction of anti-TNFa drug levels and autoantibody formation202010,527,622Antibody-based arrays for detecting multiple signal transducers in rare circulating cells202010,473,640Drug selection for gastric cancer therapy using antibody-based arrays201910,436,786Methods for detecting truncated receptors using antibody-based arrays201910,422,807Indirect homogeneous mobility shift assays for the detection of biologics in patient samples201910,401,364Drug selection for colorectal cancer therapy using receptor tyrosine kinase profiling201910,386,366Assays for the detection of anti-TNF drugs and autoantibodies201910,338,083Pathway specific markers for diagnosing irritable bowel syndrome201910,324,088Methods for establishing a vedolizumab dosing regimen to treat patients with irritable bowel disease201910,184,940Antibodies to microbiome, stress factors and mast cell markers as diagnostic markers for IBS201910,086,072Methods of disease activity profiling for personalized therapy management201810,036,757Addressable antibody arrays and methods of use201810,036,759Pathway specific markers for diagnosing irritable bowel syndrome20189,939,447Methods and compositions for analyzing proteins20189,903,867'Methods for predicting and improving the survival of colorectal cancer patients'20189,891,235'Pathway specific assays for predicting irritable bowel syndrome diagnosis'20189,851,359Ultra bright dimeric or polymeric dyes with spacing linker groups20179,835,632Biomarker panel for assessment of mucosal healing20179,784,748'Methods for determining anti-drug antibody isotypes'20179,739,786'Pathway specific markers for diagnosing irritable bowel syndrome'20179,732,385'Method for determining the risk of crohn\'s disease-related complications'20179,726,669'Biomarkers for determining sensitivity of breast cancer cells to HER2-targeted therapy'20179,719,995'Drug selection for colorectal cancer therapy using receptor tyrosine kinase profiling'20179,664,683'Profiling of signal pathway proteins to determine therapeutic efficacy'20179,575,066'Antibody-based arrays for detecting multiple signal transducers in rare circulating cells'20179,535,052'Apparatus and method for isolating leukocytes and tumor cells by filtration'20179,512,482'Compositions and methods for detecting allelic variants'20169,506,920'Assays for the detection of anti-TNF drugs and autoantibodies'20169,488,654'Methods for predicting response of triple-negative breast cancer to therapy'20169,482,672'Methods for diagnosing irritable bowel syndrome'20169,465,027'Assays for detecting neutralizing autoantibodies to biologic therapy'20169,285,369'Antibody-based arrays for detecting multiple signal transducers in rare circulating cells'20169,274,116'Drug selection for breast cancer therapy using antibody-based arrays'20169,250,243'Drug selection for lung cancer therapy using antibody-based arrays'20169,110,075'Compositions for analyzing proteins'20158,865,417'Assays for the detection of anti-TNF drugs and autoantibodies'20148,715,943'Methods for improving inflammatory bowel disease diagnosis'20148,709,733'Methods for diagnosing irritable bowel syndrome'20148,658,388'Antibody-based arrays for detecting multiple signal transducers in rate circulating cells'20148,609,349'Drug selection for breast cancer therapy using antibody-based arrays'20138,574,855'Assays for the detection of anti-TNF drugs and autoantibodies'20138,519,096'Citrullinated peptides for diagnosing and prognosing rheumatoid arthritis'2013RE044437'Methods for detecting receptor complexes comprising PI3K'20138,445,215'Assays and methods for the detection of Crohn\'s disease'20138,278,057'Addressable antibody arrays and methods of use'20128,247,180'Measuring receptor homodimerization'20128,198,031'Detecting and profiling molecular complexes'20128,163,499'Drug selection for breast cancer therapy using antibody-based arrays'20128,114,616'Methods for diagnosing irritable bowel syndrome'20127,939,267'Detection of activation of endothelial cells as surrogate marker for angiogenesis'20117,908,091'Methods of predicting and monitoring tyrosine kinase inhibitor therapy'20117,771,929'Tag library compounds, compositions, kits and methods of use'20107,709,273'Particles for diagnostic and therapeutic use'20107,648,828'Methods for detecting receptor complexes comprising PI3K'20107,537,938'Biomarker detection in circulating cells'20097,402,398'Measuring receptor homodimerization'20087,402,399'Receptor tyrosine kinase signaling pathway analysis for diagnosis and therapy'20087,402,397'Detecting and profiling molecular complexes'20087,358,052'Catalytic amplification of multiplexed assay signals'20087,279,585'Lipophilic electrophoretic probes'20077,255,999'Methods and compositions for analyzing proteins'20077,229,842'Metal chelate containing compositions for use in chemiluminescent assays'20077,217,531'Multiplex analysis using membrane-bound sensitizers'20077,160,735'Tagged microparticle compositions and methods'20077,135,300'Profiling frequencies of receptor heterodimers'20067,122,319'Multiplexed immunohistochemical assays using molecular tags'20067,105,308'Detecting receptor oligomerization'20067,041,459'Analyzing phosphorylated proteins'20067,037,654'Methods and compositions for enhancing detection in determinations employing cleavable electrophoretic tag reagents'20067,022,529'Particles for diagnostic and therapeutic use'20067,001,725'Kits employing generalized target-binding e-tag probes'20066,955,874'Kits employing oligonucleotide-binding e-tag probes'20056,949,347'Multiplex analysis using membrane-bound sensitizers'20056,916,667'Metal chelate containing compositions for use in chemiluminescent assays'20056,916,612'Sets of oligonucleotide-binding e-tag probes'20056,818,399'Methods employing generalized target-binding e-tag probes'20046,770,439'Sets of generalized target-binding e-tag probes'20046,703,248'Particles for diagnostic and therapeutic use'20046,692,975'Metal chelate containing compositions for use in chemiluminescent assays'20046,686,152'Methods employing oligonucleotide-binding e-tag probes'20046,682,887'Detection using degradation of a tagged sequence'20046,673,550'Electrophoretic tag reagents comprising fluorescent compounds'20046,649,351'Methods for detecting a plurality of analytes by mass spectrometry'20036,632,630'Monooxygenase assays'20036,632,606'Methods for single nucleotide polymorphism detection'20036,627,406'Sample evaporative control'20036,627,400'Multiplexed measurement of membrane protein populations'20036,613,525'Microfluidic apparatus and method for purification and processing'20036,555,389'Sample evaporative control'20036,514,700'Nucleic acid detection using degradation of a tagged sequence'2003D0463031'Microvolume sample plate'20026,406,667'Chemiluminescent compositions for use in detection of multiple analytes'20026,344,326'Microfluidic method for nucleic acid purification and processing'20026,340,599'Metal chelate containing compositions for use in chemiluminescent assays'20026,322,980'Single nucleotide detection using degradation of a fluorescent sequence'20016,306,273'Methods and compositions for conducting processes in microfluidic devices'20016,180,354'Metal chelate containing compositions for use in chemiluminescent assays'20016,143,514'Chemiluminescent compositions and their use in the detection of hydrogen peroxide'20006,074,827'Microfluidic method for nucleic acid purification and processing'20006,002,000'Chemiluminescent compounds and methods of use'19995,936,070'Chemiluminescent compounds and methods of use'19995,811,311'Metal chelate containing compositions for use in chemiluminescent assays'19985,780,646'Cyclic ether compounds'19985,672,478'Methods of use for and kits containing chemiluminescent compounds'19975,578,498'Metal chelate containing compositions for use in chemiluminescent assays'19965,545,834'Chemiluminescent compounds and methods of use'19965,536,834'Cyclic ether compounds'19965,532,138'Method and kits for determining peroxidatively active catalysts'1996Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1996–2018Based in San Jose, CA, US· patent location history
1998–2007Patents assigned to DADE BEHRING MARBURG GMBH (12)· patent assignee history
2000–2006Patents assigned to ACLARA BIOSCIENCES INC (22)· patent assignee history
2006–2018Patents assigned to MONOGRAM BIOSCIENCES INC (19)· patent assignee history
2008–2012Based in Los Altos, CA, US· patent location history
2011–2016Based in Los Altos Hills, CA, US· patent location history
2012–2020Patents assigned to NESTEC SA (35)· patent assignee history
2012–2019Patents assigned to SINGH SHARAT (18)· patent assignee history
2012–2020Based in Rancho Santa Fe, CA, US· patent location history
2014–2020Based in San Diego, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NESTEC SA | 35 | 2012–2020 |
| ACLARA BIOSCIENCES INC | 22 | 2000–2006 |
| MONOGRAM BIOSCIENCES INC | 19 | 2006–2018 |
| SINGH SHARATself | 18 | 2012–2019 |
| DADE BEHRING MARBURG GMBH | 12 | 1998–2007 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Jose, California, US | 54 | 1996–2018 |
| Rancho Santa Fe, California, US | 46 | 2012–2020 |
| Los Altos, California, US | 8 | 2008–2012 |
| San Diego, California, US | 4 | 2014–2020 |
| Los Altos Hills, California, US | 3 | 2011–2016 |